Formulations & Dosing

Choose from 3 dosing forms for individual patient needs: Oral Suspension, Tablets, and Injection

Oral Suspension

  • Recommended dosing1:
  • 5 mg or 20 mg TID
  • 4 to 6 hours apart
  • Treatment with doses >20 mg TID is not recommended
  • Administration1:
  • The oral suspension powder is provided in a bottle designed for constitution with 90 mL of water, regardless of dose
  • A 2-mL oral syringe and a press-in bottle adaptor are also provided

For constitution instructions, see Full Prescribing Information.

Tablets

  • Recommended dosing1:
  • 5 mg or 20 mg TID
  • 4 to 6 hours apart
  • Treatment with doses >20 mg TID is not recommended

Injection

REVATIO injection is for the continued treatment of patients with PAH who are currently prescribed oral REVATIO and who are temporarily unable to take oral medication.1

  • Recommended dosing1:
  • 2.5 mg or 10 mg TID
  • No adjustment for body weight
  • A 10-mg dose of REVATIO injection is predicted to provide pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20-mg oral dose
  • Administration1:
  • Intravenous bolus injection